Hanseatic Management Services Inc Exelixis, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$18.93 - $24.75 $497,859 - $650,925	-26,300 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$19.6 - $24.76 $515,480 - $651,188	26,300 New	26,300 $626,000
Q1 2018 May 02, 2018	SELL	$22.15 - $31.89 $72,740 - $104,726	-3,284 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $5,524 - $7,052	-228 Reduced 6.49%	3,284 $100,000
Q3 2017 Nov 07, 2017	BUY	$23.35 - $29.24 $17,255 - $21,608	739 Added 26.65%	3,512 $85,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,773	2,773 $68,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.